insights_auto
Why is KROS down 2.72%?
Dive Deeperchevron_right
KROS:NASDAQ
Keros Therapeutics Inc
$11.08
arrow_downward
-2.72%(-0.31) 1D
$11.08
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 20, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KROS...
Open
$11.18
High
$11.59
Low
$10.95
Mkt. cap
217.44M
Avg. vol.
210.29K
Volume
207.91K
52-wk high
$22.55
52-wk low
$8.98
EPS
-$2.83
Beta
1.13
Shares outstanding
19.62M
No. of employees
87
Open
$11.18
High
$11.59
Low
$10.95
Mkt. cap
217.44M
Avg. vol.
210.29K
Volume
207.91K
52-wk high
$22.55
52-wk low
$8.98
EPS
-$2.83
Beta
1.13
Shares outstanding
19.62M
No. of employees
87
News stories
From web sources and news partners
Investing.com India
·
10 hours ago
Keros Therapeutics director Charles Newton disposes of $5,980 in shares By Investing.com
Investing.com UK
·
10 hours ago
Anne Prener, Keros Therapeutics director, sells $6,229 in shares By Investing.com
Zacks
·
1 day ago
What Makes Keros Therapeutics (KROS) a New Strong Buy Stock
Zacks
·
1 day ago
Best Momentum Stocks to Buy for November 19th
About Keros Therapeutics Inc
CEO-
Employees87
Founded2015
HeadquartersLexington, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitekerostx.com